These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 719462

  • 21. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B, Hauw JJ, Ruberg M, Serdaru M, Javoy-Agid F, Agid Y.
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [Abstract] [Full Text] [Related]

  • 22. Brain glutamate decarboxylase and cholinergic enzyme activities in scrapie.
    Iqbal K, Somerville RA, Thompson CH, Wisniewski HM.
    J Neurol Sci; 1985 Mar; 67(3):345-50. PubMed ID: 4039359
    [Abstract] [Full Text] [Related]

  • 23. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.
    Bowen DM, Smith CB, White P, Davison AN.
    Brain; 1976 Sep; 99(3):459-96. PubMed ID: 11871
    [Abstract] [Full Text] [Related]

  • 24. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
    Rossor M, Fahrenkrug J, Emson P, Mountjoy C, Iversen L, Roth M.
    Brain Res; 1980 Nov 10; 201(1):249-53. PubMed ID: 7417838
    [Abstract] [Full Text] [Related]

  • 25. VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type.
    Danielsson E, Eckernäs SA, Westlind-Danielsson A, Nordström O, Bartfai T, Gottfries CG, Wallin A.
    Neurobiol Aging; 1988 Nov 10; 9(2):153-62. PubMed ID: 2897639
    [Abstract] [Full Text] [Related]

  • 26. Cholinergic deficit in frontal cerebral cortex in Alzheimer's disease is age dependent.
    Rossor MN, Iversen LL, Johnson AJ, Mountjoy CQ, Roth M.
    Lancet; 1988 Nov 10; 2(8260-61):1422. PubMed ID: 6118790
    [No Abstract] [Full Text] [Related]

  • 27. Bilateral symmetry of cholinergic deficits in Alzheimer's disease.
    Zubenko GS, Moossy J, Hanin I, Martinez AJ, Rao GR, Kopp U.
    Arch Neurol; 1988 Mar 10; 45(3):255-9. PubMed ID: 3341949
    [Abstract] [Full Text] [Related]

  • 28. Acetylcholinesterase fibers and the development of senile plaques.
    Tago H, McGeer PL, McGeer EG.
    Brain Res; 1987 Mar 17; 406(1-2):363-9. PubMed ID: 3567634
    [Abstract] [Full Text] [Related]

  • 29. Cortical cholinergic markers in schizophrenia.
    Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, Davis KL.
    Schizophr Res; 1994 May 17; 12(2):137-44. PubMed ID: 8043524
    [Abstract] [Full Text] [Related]

  • 30. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia.
    Sakurada T, Alufuzoff I, Winblad B, Nordberg A.
    Brain Res; 1990 Jun 25; 521(1-2):329-32. PubMed ID: 1698512
    [Abstract] [Full Text] [Related]

  • 31. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.
    Perry EK, Blessed G, Tomlinson BE, Perry RH, Crow TJ, Cross AJ, Dockray GJ, Dimaline R, Arregui A.
    Neurobiol Aging; 1981 Jun 25; 2(4):251-6. PubMed ID: 6174877
    [Abstract] [Full Text] [Related]

  • 32. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
    Armstrong DM, Bruce G, Hersh LB, Terry RD.
    Neurosci Lett; 1986 Nov 11; 71(2):229-34. PubMed ID: 2431362
    [Abstract] [Full Text] [Related]

  • 33. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA.
    Prog Brain Res; 1986 Nov 11; 70():105-32. PubMed ID: 3554348
    [No Abstract] [Full Text] [Related]

  • 34. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.
    Perry RH, Candy JM, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE.
    Neurosci Lett; 1982 Dec 13; 33(3):311-5. PubMed ID: 7162693
    [Abstract] [Full Text] [Related]

  • 35. Alzheimer-like cholinergic deficiency in Down syndrome.
    Yates CM, Simpson J, Maloney AF, Gordon A, Reid AH.
    Lancet; 1980 Nov 01; 2(8201):979. PubMed ID: 6107618
    [No Abstract] [Full Text] [Related]

  • 36. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.
    Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A.
    Ann Neurol; 1988 Feb 01; 23(2):138-44. PubMed ID: 2897823
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.
    Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE.
    J Neurol Sci; 1983 May 01; 59(2):277-89. PubMed ID: 6854353
    [Abstract] [Full Text] [Related]

  • 39. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.
    Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, McKeith IG.
    Neuroreport; 1994 Mar 21; 5(7):747-9. PubMed ID: 8018843
    [Abstract] [Full Text] [Related]

  • 40. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain.
    Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL.
    Am J Psychiatry; 2001 Jul 21; 158(7):1058-66. PubMed ID: 11431227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.